High doses of taurolidine inhibit advanced intraperitoneal tumor growth in rats

Journal of Surgical Research

Volumn 129, Issue 1, 2005, Pages 129-135

  Braumann, Chris ^a,b,c   Stuhldreier, Benedikt ^a   Bobrich, Eva ^a   Menenakos, Charalambos ^a   Rogalla, Stephan ^a   Jacobi, Christoph A ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Division of Molecular Biology   (Germany)

Author keywords

Intraperitoneal; Progressive tumor; Rat; Taurolidine; Toxicity

Indexed keywords

RINGER SOLUTION; TAUROLIDINE;

ADVANCED CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL COUNT; BODY WEIGHT; CANCER CELL CULTURE; CATHETER; CATHETER INFECTION; COLON ADENOCARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; HISTOPATHOLOGY; KIDNEY INJURY; LAPAROTOMY; LIVER INJURY; LIVER TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; ORGAN INJURY; PERITONEUM TUMOR; PRIORITY JOURNAL; RANDOMIZATION; SUPERIOR CAVA VEIN; SYSTEMIC DISEASE; TIME; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR LOCALIZATION;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; BIOPSY; CELL DIVISION; CELL LINE, TUMOR; COLONIC NEOPLASMS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; KIDNEY; KIDNEY DISEASES; LIVER; LIVER DISEASES; MALE; NEOPLASM TRANSPLANTATION; PERITONEAL NEOPLASMS; RATS; TAURINE; THIADIAZINES;

EID: 26244439461     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2005.03.012     Document Type: Article

References (33)

1. R.W. Pfirrmann Einführung und Übersicht W.L. Brückner R.W. Pfirrmann Taurolin-Ein neues Konzept zur antimikrobiellen Chemotherapie chirurgischer Infektionen 1985 Donauwoerth Urban & Schwarzenberg
2. P. Calabresi, F.A. Goulette, J.W. Darnowski Taurolidine cytotoxic and mechanistic evaluation of a novel antineoplastic agent Cancer Res 61 2001 6816
3. R. Stendel, G. Stoltenburg-Didinger, C.L. Al Keikh The effect of taurolidine on brain tumor cells Anticancer Res 22 2002 809
4. L. Petrovic, K.A. Schlegel, J. Ries In-vitro-effect von Taurolidin auf Plattenepithelkarzinomzellen der Mundhöhle Mund Kiefer GesichtsChir 7 2003 102
5. C. Braumann, W. Henke, C.A. Jacobi The tumour suppressive reagent taurolidine is an inhibitor of protein biosynthesis Int. J. Cancer 112 2004 225
6. C.A. Jacobi, F.J. Peter, F.A. Wenger New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy results of a tumor model in the rat Dig. Surg 16 1999 393
7. C.A. Jacobi, P. Wildbrett, T. Volk Influence of different gases and intraperitoneal instillation of antiadherent or cytotoxic agents on peritoneal tumor cell growth and implantation with laparoscopic surgery in a rat model Surg. Endosc 13 1999 1021
8. C. Braumann, J. Ordemann, M. Kilian Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy Clin. Exp. Metastasis 20 2003 387
9. C. Braumann, J. Ordemann, P. Wildbrett Influence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats Clin. Exp. Metastasis 18 2000 547
10. F.A. Wenger, M. Kilian, C. Braumann Effects of taurolidine and octreotide on port site and liver metastasis after laparoscopy in an animal model of pancreatic cancer Clin. Exp. Metastasis 19 2002 169
11. M. Kilian, I. Mautsch, C. Braumann Effects of taurolidine and octreotide on tumor growth and lipid peroxidation after staging-laparoscopy in ductal pancreatic cancer Prostaglandins Leukot. Essent. Fatty Acids 69 2003 261
12. J.W. Darnowski, F.A. Goulette, L.P. Cousens Mechanistic and antineoplastic evaluation of taurolidine in the DU 145 model of human prostate cancer Cancer Chemother. Pharmacol 54 2004 249
13. K. Ishak, A. Baptista, L. Bianchi Histological grading and staging of chronic hepatitis J. Hepatol 22 1995 96
14. L.C. Racusen, K. Solez, R.B. Colvin The Banff 97 working classification of renal allograft pathology Kidney Int 55 1999 713
15. M.L. Da Costa, H.P. Redmond, D.J. Bouchier-Hayes Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumor and development of organ metastases from circulating tumor cells released following surgery J. Surg. Res 101 2001 111
16. M.L. Leithauser, P.M. Rob, K. Sack Pentoxifylline, cyclosporine A and taurolidine inhibit endotoxin-stimulated tumor necrosis factor-alpha production in rat mesangial cell cultures Exp. Nephrol 5 1997 100
17. Z. Han, I. Ribbizi, P. Pantazis The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanism Anticancer Res 22 2002 1959
18. D.P. Shrayer, H. Lukoff, T. King The effect of Taurolidine on adherent and floating subpopulations of melanoma cells Anticancer Drugs 14 2003 295
19. M. McCourt, J.H. Wang, S. Sookhai Taurolidine inhibits tumor cell growth in vitro and in vivo Ann. Surg. Oncol 7 2000 685
20. R. Stendel, L. Scheurer, G. Stoltenburg-Didinger Enhancement of Fas-ligand-mediated programmed cell death by taurolidine Anticancer Res 23 2003 2309
21. P. Wittich, A. Mearadji, R.L. Marquet Irrigation of port sites prevention of port site metastases J. Laparoendosc. Adv. Surg. Techn 14 2004 125
22. R. Stendel, T. Picht, A. Schilling Treatment of glioblastoma with intravenous taurolidine. First clinical experience Anticancer Res 24 2004 1143
23. I. Bedrosian, R.D. Sofia, S.M. Wolff Taurolidine. An analogue of the amino acid taurine, suppresses interleucin-1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells Cytokine 3 1991 568
24. M. Yanagisawa, H. Imai, Y. Fukushima Effects on tumor necrosis factor alpha and interleukin 1 beta on the proliferation of cultured glomerular epithelial cells Virchows Arch 426 1994 581
25. L. Nici, B. Monfils, P. Calabresi The effects of taurolidine, a novel antineoplastic agent, on human mesothelioma Clin. Cancer Res 10 2004 7655
26. J. Volz, S. Volz-Koster, S. Kanis Modulation of tumor induced lethality after pneumoperitoneum in a mouse model Cancer 89 2000 262
27. L. Lanfrancone, D. Boraschi, P. Ghiara Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor, granulocyte-monocyte CSF, macrophage CSF, IL-1 and IL-2) and are activated and stimulated to grow by IL-1 Blood 80 1992 2835
28. H. Torisu, M. Ono, H. Kiryu Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma possible involvement of TNFalpha and IL-1alpha Int. J. Cancer 85 2000 182
29. D.J. Van Antwerp, S.J. Martin, I.M. Verma Inhibition of TNF-induced apoptosis by NF-kappa B Trends Cell Biol 8 1998 107
30. C. Braumann, M. Schoenbeck, C. Meneakos Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on metastatic tumor growth in rats Clin. Exp. Metastasis 2004 (in press)
31. I. Ribizzi, J.W. Darnowski, F.A. Goulette Taurolidine. preclinical evaluation of a novel, highly selective, agent for bone marrow purging Bone Marrow Transplant 29 2002 313
32. M.G.H. Betjes, M. van Agteren Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution Nephrol. Dial. Transplant 19 2004 1546
33. B. Jurewitsch, T. Lee, J. Park Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections JPEN J. Parenter. Enteral. Nutr 22 1998 242